Predictors of Early Neurological Deterioration and Functional Outcome in Acute Ischemic Stroke: The Importance of Large Artery Disease, Hyperglycemia and Inflammatory Blood Biomarkers

References

• Nacu A, Bringeland GH, Khanevski A, Thomassen L, Waje-Andreassen U, Naess H. Early neurological worsening in acute ischaemic stroke patients. Acta Neurol Scand. 2016;133(1):25–29. doi:10.1111/ane.12418
   Web of Science ®Google Scholar
• Seners P, Turc G, Oppenheim C, Baron JC. Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications. J Neurol Neurosurg Psychiatry. 2015;86(1):87–94. doi:10.1136/jnnp-2014-308327
   PubMed Web of Science ®Google Scholar
• Geng HH, Wang Q, Li B, et al. Early neurological deterioration during the acute phase as a predictor of long-term outcome after first-ever ischemic stroke. Medicine. 2017;96(51):e9068. doi:10.1097/MD.0000000000009068
   Web of Science ®Google Scholar
• Ferrari J, Knoflach M, Kiechl S, et al. Early clinical worsening in patients with TIA or minor stroke: the Austrian Stroke Unit Registry. Neurology. 2010;74(2):136–141. doi:10.1212/WNL.0b013e3181c9188b
   Web of Science ®Google Scholar
• Thanvi B, Treadwell S, Robinson T. Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management. Postgrad Med J. 2008;84(994):412–417. doi:10.1136/pgmj.2007.066118
   Web of Science ®Google Scholar
• Alawneh JA, Moustafa RR, Baron JC. Hemodynamic factors and perfusion abnormalities in early neurological deterioration. Stroke. 2009;40(6):e443–450. doi:10.1161/STROKEAHA.108.532465
   PubMed Web of Science ®Google Scholar
• Kwan J, Hand P. Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. QJM. 2006;99(9):625–633. doi:10.1093/qjmed/hcl082
   PubMed Web of Science ®Google Scholar
• Wiryadana KA, Supadmanaba IGP, Samatra D. Progress and potential roles blood biomarkers of ischemic stroke in clinical setting. Indones J Biomed Sci. 2017;11(2):19–29. doi:10.15562/ijbs.v11i2.138
   Google Scholar
• Saleem Y, Nogueira RG, Rodrigues GM, et al. Acute neurological deterioration in large vessel occlusions and mild symptoms managed medically. Stroke. 2020;51(5):1428–1434. doi:10.1161/STROKEAHA.119.027011
   PubMed Web of Science ®Google Scholar
• Xie X, Xiao J, Wang Y, et al. Predictive model of early neurological deterioration in patients with acute Ischemic stroke: a Retrospective Cohort Study. J Stroke Cerebrovasc Dis. 2021;30(3):105459. doi:10.1016/j.jstrokecerebrovasdis.2020.105459
   Web of Science ®Google Scholar
• Martin AJ, Price CI. A systematic review and meta-analysis of molecular biomarkers Associated with Early Neurological Deterioration Following Acute Stroke. Cerebrovasc Dis. 2018;46(5–6):230–241. doi:10.1159/000495572
   PubMed Web of Science ®Google Scholar
• Kim JM, Moon J, Ahn SW, Shin HW, Jung KH, Park KY. The etiologies of early neurological deterioration after thrombolysis and risk factors of Ischemia progression. J Stroke Cerebrovasc Dis. 2016;25(2):383–388. doi:10.1016/j.jstrokecerebrovasdis.2015.10.010
   PubMed Web of Science ®Google Scholar
• Seners P, Turc G, Tisserand M, et al. Unexplained early neurological deterioration after intravenous thrombolysis: incidence, predictors, and associated factors. Stroke. 2014;45(7):2004–2009. doi:10.1161/STROKEAHA.114.005426
   PubMed Web of Science ®Google Scholar
• Simonsen CZ, Schmitz ML, Madsen MH, et al. Early neurological deterioration after thrombolysis: clinical and imaging predictors. Int J Stroke. 2016;11(7):776–782. doi:10.1177/1747493016650454
   PubMed Web of Science ®Google Scholar
• Siegler JE, Boehme AK, Albright KC, et al. A proposal for the classification of etiologies of neurologic deterioration after acute ischemic stroke. J Stroke Cerebrovasc Dis. 2013;22(8):e549–556. doi:10.1016/j.jstrokecerebrovasdis.2013.06.012
   Web of Science ®Google Scholar
• Seners P, Hurford R, Tisserand M, et al. Is unexplained early neurological deterioration after intravenous Thrombolysis Associated With Thrombus Extension? Stroke. 2017;48(2):348–352. doi:10.1161/STROKEAHA.116.015414
   PubMed Web of Science ®Google Scholar
• Roquer J, Rodríguez-Campello A, Gomis M, et al. Acute stroke unit care and early neurological deterioration in ischemic stroke. J Neurol. 2008;255(7):1012–1017. doi:10.1007/s00415-008-0820-z
   Web of Science ®Google Scholar
• Shimoyama T, Kimura K, Uemura J, Saji N, Shibazaki K. Elevated glucose level adversely affects infarct volume growth and neurological deterioration in non-diabetic stroke patients, but not diabetic stroke patients. Eur J Neurol. 2014;21(3):402–410. doi:10.1111/ene.12280
   PubMed Web of Science ®Google Scholar
• Sumer M, Ozdemir I, Erturk O. Progression in acute ischemic stroke: frequency, risk factors and prognosis. J Clin Neurosci. 2003;10(2):177–180. doi:10.1016/S0967-5868(02)00325-9
   PubMed Web of Science ®Google Scholar
• Ng GJL, Quek AML, Cheung C, Arumugam TV, Seet RCS. Stroke biomarkers in clinical practice: a critical appraisal. Neurochem Int. 2017;107:11–22. doi:10.1016/j.neuint.2017.01.005
   PubMed Web of Science ®Google Scholar
• Pandey A, Shrivastava AK, Saxena K. Neuron specific enolase and c-reactive protein levels in stroke and its subtypes: correlation with degree of disability. Neurochem Res. 2014;39(8):1426–1432. doi:10.1007/s11064-014-1328-9
   Web of Science ®Google Scholar
• Whiteley W, Wardlaw J, Dennis M, et al. The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke. 2012;43(1):86–91. doi:10.1161/STROKEAHA.111.634089
   PubMed Web of Science ®Google Scholar
• Deng QW, Huang S, Li S, et al. Inflammatory factors as potential markers of early neurological deterioration in acute ischemic stroke patients receiving endovascular therapy - the AISRNA Study. J Inflamm Res. 2021;14:4399–4407. doi:10.2147/JIR.S317147
   PubMed Web of Science ®Google Scholar
• Vila N, Castillo J, Dávalos A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke. 2000;31(10):2325–2329. doi:10.1161/01.STR.31.10.2325
   PubMed Web of Science ®Google Scholar
• Seners P, Baron JC. Revisiting ‘progressive stroke’: incidence, predictors, pathophysiology, and management of unexplained early neurological deterioration following acute ischemic stroke. J Neurol. 2018;265(1):216–225. doi:10.1007/s00415-017-8490-3
   PubMed Web of Science ®Google Scholar
• Wigzell O Nationella riktlinjer för vård vid stroke. [National guidelines for stroke care] The Social welfare board of Sweden; 2020. Available from: www.socialstyrelsen.se. Accessed August 18, 2022.
   Google Scholar
• Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41. doi:10.1161/01.STR.24.1.35
   PubMed Web of Science ®Google Scholar
• Dewey HM, Donnan GA, Freeman EJ, et al. Interrater reliability of the National Institutes of health stroke scale: rating by neurologists and nurses in a community-based stroke incidence study. Cerebrovasc Dis. 1999;9(6):323–327. doi:10.1159/000016006
   PubMed Web of Science ®Google Scholar
• Liu P, Liu S, Feng N, Wang Y, Gao Y, Wu J. Association between neurological deterioration and outcomes in patients with stroke. Ann Transl Med. 2020;8(1):4. doi:10.21037/atm.2019.12.36
   Web of Science ®Google Scholar
• Lee SJ, Lee DG. Distribution of atherosclerotic stenosis determining early neurologic deterioration in acute ischemic stroke. PLoS One. 2017;12(9):e0185314. doi:10.1371/journal.pone.0185314
   PubMed Web of Science ®Google Scholar
• Parsons MW, Barber PA, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52(1):20–28. doi:10.1002/ana.10241
   PubMed Web of Science ®Google Scholar
• Rosso C, Corvol JC, Pires C, et al. Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial. Stroke. 2012;43(9):2343–2349. doi:10.1161/STROKEAHA.112.657122
   PubMed Web of Science ®Google Scholar
• Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JC, Hoekstra JB. Hyperglycemia: a prothrombotic factor? J Thromb Haemost. 2010;8(8):1663–1669. doi:10.1111/j.1538-7836.2010.03910.x
   PubMed Web of Science ®Google Scholar
• Beard DJ, McLeod DD, Logan CL, et al. Intracranial pressure elevation reduces flow through collateral vessels and the penetrating arterioles they supply. A possible explanation for ‘collateral failure’ and infarct expansion after ischemic stroke. J Cereb Blood Flow Metab. 2015;35(5):861–872. doi:10.1038/jcbfm.2015.2
   Web of Science ®Google Scholar
• Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke. 2002;33(10):2459–2464. doi:10.1161/01.STR.0000029828.51413.82
   PubMed Web of Science ®Google Scholar
• Irvine HJ, Battey TW, Ostwaldt AC, et al. Early neurological stability predicts adverse outcome after acute ischemic stroke. Int J Stroke. 2016;11(8):882–889. doi:10.1177/1747493016654484
   PubMed Web of Science ®Google Scholar
• Naveen V, Vengamma B, Mohan A, Vanajakshamma V. N-terminal pro-brain natriuretic peptide levels and short term prognosis in acute ischemic stroke. Ann Indian Acad Neurol. 2015;18(4):435–440. doi:10.4103/0972-2327.165478
   PubMed Web of Science ®Google Scholar
• Chen X, Zhan X, Chen M, et al. The prognostic value of combined NT-pro-BNP levels and NIHSS scores in patients with acute ischemic stroke. Intern Med. 2012;51(20):2887–2892. doi:10.2169/internalmedicine.51.8027
   PubMed Web of Science ®Google Scholar
• Chang L, Yan H, Li H, et al. N-terminal probrain natriuretic peptide levels as a predictor of functional outcomes in patients with ischemic stroke. Neuroreport. 2014;25(13):985–990. doi:10.1097/WNR.0000000000000195
   PubMed Web of Science ®Google Scholar
• Katsuki M, Kakizawa Y, Nishikawa A, Yamamoto Y, Uchiyama T. Temporal muscle thickness and area are an independent prognostic factors in patients aged 75 or younger with aneurysmal subarachnoid hemorrhage treated by clipping. Surg Neurol Int. 2021;12:151. doi:10.25259/SNI_814_2020
   PubMedGoogle Scholar
• Furtner J, Weller M, Weber M, et al. Temporal muscle thickness as a prognostic marker in patients with newly diagnosed glioblastoma: translational imaging analysis of the CENTRIC EORTC 26071–22072 and CORE Trials. Clin Cancer Res. 2022;28(1):129–136. doi:10.1158/1078-0432.CCR-21-1987
   Web of Science ®Google Scholar
• Zhang X, Sun Z, Ding C, et al. Metabolic syndrome augments the risk of early neurological deterioration in acute ischemic stroke patients Independent of Inflammatory Mediators: a Hospital-Based Prospective Study. Oxid Med Cell Longev. 2016;2016:8346301. doi:10.1155/2016/8346301
   Web of Science ®Google Scholar
• Montellano FA, Ungethüm K, Ramiro L, et al. Role of blood-based biomarkers in ischemic stroke prognosis: a systematic review. Stroke. 2021;52(2):543–551. doi:10.1161/STROKEAHA.120.029232
   Web of Science ®Google Scholar
• Glushakova OY, Glushakov AV, Miller ER, Valadka AB, Hayes RL. Biomarkers for acute diagnosis and management of stroke in neurointensive care units. Brain Circ. 2016;2(1):28–47. doi:10.4103/2394-8108.178546
   PubMedGoogle Scholar